These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36222177)

  • 1. Population pharmacokinetics of sublingually administered tacrolimus in infants and young children with liver transplantation.
    Riva N; Ibarra M; Parra-Guillen ZP; Galván ME; Pérez E; Trezeguet Renatti G; Cáceres Guido P; Lopez C; Licciardone N; Halac E; Dip M; Cruz A; Imventarza O; Buamscha D; Troconiz IF; Schaiquevich P
    Br J Clin Pharmacol; 2023 Mar; 89(3):1115-1126. PubMed ID: 36222177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
    Sam WJ; Aw M; Quak SH; Lim SM; Charles BG; Chan SY; Ho PC
    Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
    Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
    Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients.
    Lu Z; Bonate P; Keirns J
    Br J Clin Pharmacol; 2019 Aug; 85(8):1692-1703. PubMed ID: 30950096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z; Dashti-Khavidaki S; Nasiri-Toosi M; Khalili H; Jafarian A; Irajian H; Abdollahi A; Sadrai S
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
    Kassir N; Labbé L; Delaloye JR; Mouksassi MS; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Théorêt Y; Litalien C
    Br J Clin Pharmacol; 2014 Jun; 77(6):1051-63. PubMed ID: 24977292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
    Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
    Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Variability of Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation.
    Sikma MA; Hunault CC; Van Maarseveen EM; Huitema ADR; Van de Graaf EA; Kirkels JH; Verhaar MC; Grutters JC; Kesecioglu J; De Lange DW
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):123-134. PubMed ID: 31745812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants.
    Staatz CE; Taylor PJ; Lynch SV; Willis C; Charles BG; Tett SE
    Transplantation; 2001 Sep; 72(6):1056-61. PubMed ID: 11579300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
    Guy-Viterbo V; Baudet H; Elens L; Haufroid V; Lacaille F; Girard M; Debray D; Chardot C; Reding R; Wallemacq P; Musuamba F
    Pharmacogenomics; 2014 Jun; 15(9):1207-21. PubMed ID: 25141896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.
    Musuamba FT; Guy-Viterbo V; Reding R; Verbeeck RK; Wallemacq P
    Ther Drug Monit; 2014 Feb; 36(1):54-61. PubMed ID: 24081207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
    Antignac M; Hulot JS; Boleslawski E; Hannoun L; Touitou Y; Farinotti R; Lechat P; Urien S
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):409-16. PubMed ID: 15991041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
    Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
    Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation.
    Guy-Viterbo V; Scohy A; Verbeeck RK; Reding R; Wallemacq P; Musuamba FT
    Eur J Clin Pharmacol; 2013 Aug; 69(8):1533-42. PubMed ID: 23588560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.